These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35563363)

  • 21. Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets.
    Xu Y; Jiang H; Li L; Chen F; Liu Y; Zhou M; Wang J; Jiang J; Li X; Fan X; Zhang L; Zhang J; Qiu J; Wu Y; Fang C; Sun H; Liu J
    Circulation; 2020 Jul; 142(1):49-64. PubMed ID: 32200651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic Inflammation.
    Jagadapillai R; Rane MJ; Lin X; Roberts AM; Hoyle GW; Cai L; Gozal E
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dual role of platelet-innate immune cell interactions in thrombo-inflammation.
    Rayes J; Bourne JH; Brill A; Watson SP
    Res Pract Thromb Haemost; 2020 Jan; 4(1):23-35. PubMed ID: 31989082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement activation on platelets: implications for vascular inflammation and thrombosis.
    Peerschke EI; Yin W; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2170-5. PubMed ID: 20621693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New paradigms in thrombosis: novel mediators and biomarkers platelet RNA transfer.
    Clancy L; Freedman JE
    J Thromb Thrombolysis; 2014 Jan; 37(1):12-6. PubMed ID: 24163053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Roles of GRKs in Hemostasis and Thrombosis.
    Chen X; Zhao X; Cooper M; Ma P
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.
    Jarre A; Gowert NS; Donner L; Münzer P; Klier M; Borst O; Schaller M; Lang F; Korth C; Elvers M
    Cell Signal; 2014 Sep; 26(9):2040-50. PubMed ID: 24928203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelets as Potent Signaling Entities in Type 2 Diabetes Mellitus.
    Pretorius E
    Trends Endocrinol Metab; 2019 Aug; 30(8):532-545. PubMed ID: 31196615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.
    Gasparyan AY; Stavropoulos-Kalinoglou A; Mikhailidis DP; Douglas KM; Kitas GD
    Rheumatol Int; 2011 Feb; 31(2):153-64. PubMed ID: 20390282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet abnormalities in diabetes mellitus.
    Ferreiro JL; Gómez-Hospital JA; Angiolillo DJ
    Diab Vasc Dis Res; 2010 Oct; 7(4):251-9. PubMed ID: 20921090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology.
    Chatterjee M
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stachydrine exhibits a novel antiplatelet property and ameliorates platelet-mediated thrombo-inflammation.
    Sun X; Zhou M; Pu J; Wang T
    Biomed Pharmacother; 2022 Aug; 152():113184. PubMed ID: 35679717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus and thrombosis.
    Vazzana N; Ranalli P; Cuccurullo C; Davì G
    Thromb Res; 2012 Mar; 129(3):371-7. PubMed ID: 22197180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications.
    Vito CD; Hadi LA; Navone SE; Marfia G; Campanella R; Mancuso ME; Riboni L
    Platelets; 2016 Jul; 27(5):393-401. PubMed ID: 26950429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.
    Lievens D; Zernecke A; Seijkens T; Soehnlein O; Beckers L; Munnix IC; Wijnands E; Goossens P; van Kruchten R; Thevissen L; Boon L; Flavell RA; Noelle RJ; Gerdes N; Biessen EA; Daemen MJ; Heemskerk JW; Weber C; Lutgens E
    Blood; 2010 Nov; 116(20):4317-27. PubMed ID: 20705757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting platelet receptors in thrombotic and thrombo-inflammatory disorders.
    Vögtle T; Cherpokova D; Bender M; Nieswandt B
    Hamostaseologie; 2015; 35(3):235-43. PubMed ID: 25634564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients.
    El Haouari M
    Curr Med Chem; 2019; 26(22):4145-4165. PubMed ID: 28982316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging roles for platelets as immune and inflammatory cells.
    Morrell CN; Aggrey AA; Chapman LM; Modjeski KL
    Blood; 2014 May; 123(18):2759-67. PubMed ID: 24585776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet abnormalities in diabetes mellitus.
    Winocour PD
    Diabetes; 1992 Oct; 41 Suppl 2():26-31. PubMed ID: 1526332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of oxidative stress on platelet hyperreactivity during aging.
    Fuentes E; Palomo I
    Life Sci; 2016 Mar; 148():17-23. PubMed ID: 26872977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.